ATE388947T1 - Escitalopramhydrobromid und ein verfahren zu dessen herstellung - Google Patents

Escitalopramhydrobromid und ein verfahren zu dessen herstellung

Info

Publication number
ATE388947T1
ATE388947T1 AT03779759T AT03779759T ATE388947T1 AT E388947 T1 ATE388947 T1 AT E388947T1 AT 03779759 T AT03779759 T AT 03779759T AT 03779759 T AT03779759 T AT 03779759T AT E388947 T1 ATE388947 T1 AT E388947T1
Authority
AT
Austria
Prior art keywords
production
escitalopram hydrobromide
escitalopram
hydrobromide
Prior art date
Application number
AT03779759T
Other languages
English (en)
Inventor
Lawrence Martel
Robert Dancer
Hans Petersen
Peter Ellegaard
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32668635&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE388947(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Application granted granted Critical
Publication of ATE388947T1 publication Critical patent/ATE388947T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
AT03779759T 2002-12-23 2003-12-18 Escitalopramhydrobromid und ein verfahren zu dessen herstellung ATE388947T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200202005 2002-12-23

Publications (1)

Publication Number Publication Date
ATE388947T1 true ATE388947T1 (de) 2008-03-15

Family

ID=32668635

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03779759T ATE388947T1 (de) 2002-12-23 2003-12-18 Escitalopramhydrobromid und ein verfahren zu dessen herstellung

Country Status (33)

Country Link
US (1) US20040167209A1 (de)
EP (1) EP1578738B1 (de)
JP (2) JP4658613B2 (de)
KR (1) KR20050086933A (de)
CN (1) CN100349885C (de)
AR (1) AR042652A1 (de)
AT (1) ATE388947T1 (de)
AU (1) AU2003287919B2 (de)
BR (1) BR0317623A (de)
CA (1) CA2511142A1 (de)
CY (1) CY1107451T1 (de)
DE (1) DE60319739T2 (de)
DK (1) DK1578738T3 (de)
EA (1) EA013116B1 (de)
EG (1) EG24729A (de)
ES (1) ES2298595T3 (de)
HK (1) HK1087708A1 (de)
IL (1) IL169125A0 (de)
IS (1) IS2654B (de)
ME (1) MEP5808A (de)
MX (1) MXPA05005772A (de)
MY (1) MY135468A (de)
NO (1) NO20053595L (de)
NZ (1) NZ540281A (de)
PE (1) PE20040924A1 (de)
PL (1) PL378275A1 (de)
PT (1) PT1578738E (de)
RS (1) RS51092B (de)
TW (1) TW200501943A (de)
UA (1) UA80170C2 (de)
UY (1) UY28148A1 (de)
WO (1) WO2004056791A1 (de)
ZA (1) ZA200504109B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004056791A1 (en) * 2002-12-23 2004-07-08 H. Lundbeck A/S Escitalopram hydrobromide and a method for the preparation thereof
US20050137255A1 (en) * 2002-12-23 2005-06-23 H. Lundbeck A/S Crystalline escitalopram hydrobromide and methods for preparing the same
AU2005218713B2 (en) * 2004-03-05 2009-11-19 H. Lundbeck A/S Crystalline composition containing escitalopram oxalate
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI347942B (en) 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN101374507A (zh) * 2005-10-14 2009-02-25 H.隆德贝克有限公司 含有依他普仑和安非他酮的稳定药物制剂
JP2009511606A (ja) * 2005-10-14 2009-03-19 ハー・ルンドベック・アクチエゼルスカベット エスシタロプラムおよびブプロピオンの低用量の併用を用いる中枢神経系障害の治療方法
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram
WO2008007691A1 (fr) * 2006-07-11 2008-01-17 Mitsubishi Tanabe Pharma Corporation Sels de composé de morpholine
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
FR3006594A1 (fr) * 2013-06-11 2014-12-12 Sorin Crm Sas Microsonde implantable de detection/stimulation incorporant un agent anti-inflammatoire
CN108976188B (zh) * 2017-06-05 2022-12-06 上海奥博生物医药股份有限公司 一种艾司西酞普兰双羟萘酸盐新的制备方法
KR102505669B1 (ko) * 2017-10-09 2023-03-03 428 파마 비브이 에스시탈로프람의 새로운 염 및 고상형
EP4277661A1 (de) 2021-01-18 2023-11-22 Anton Frenkel Pharmazeutische darreichungsform

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34712A (en) * 1862-03-18 James h
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
EA002977B1 (ru) * 1998-10-20 2002-12-26 Х.Лундбекк А/С Способ получения циталопрама
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
NZ512406A (en) * 1999-10-25 2004-01-30 H Method for the preparation of citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
JP2002020379A (ja) * 2000-05-02 2002-01-23 Sumika Fine Chemicals Co Ltd シタロプラム臭化水素酸塩の結晶およびその結晶化方法
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram
AU2002224906B2 (en) * 2000-12-04 2006-03-30 Westfalia Separator Ag Method for pretreating crude oils and raw fats for the production of fatty acid esters
CA2445843A1 (en) * 2001-05-01 2002-11-07 H. Lundbeck A/S The use of enantiomeric pure escitalopram
AR034612A1 (es) 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
WO2004056791A1 (en) * 2002-12-23 2004-07-08 H. Lundbeck A/S Escitalopram hydrobromide and a method for the preparation thereof
US20050174782A1 (en) * 2003-03-25 2005-08-11 Chapman Leonard T. Flashlight

Also Published As

Publication number Publication date
ZA200504109B (en) 2006-08-30
CN1726202A (zh) 2006-01-25
RS20050487A (en) 2007-06-04
AU2003287919A1 (en) 2004-07-14
US20040167209A1 (en) 2004-08-26
IS7848A (is) 2005-05-17
KR20050086933A (ko) 2005-08-30
EG24729A (en) 2010-06-21
EA200501046A1 (ru) 2005-12-29
EP1578738B1 (de) 2008-03-12
DE60319739T2 (de) 2008-07-17
IS2654B (is) 2010-08-15
WO2004056791A1 (en) 2004-07-08
HK1087708A1 (en) 2006-10-20
JP2006514952A (ja) 2006-05-18
CY1107451T1 (el) 2012-12-19
NZ540281A (en) 2008-07-31
UY28148A1 (es) 2004-09-30
MXPA05005772A (es) 2005-08-16
EA013116B1 (ru) 2010-02-26
EP1578738A1 (de) 2005-09-28
RS51092B (sr) 2010-10-31
DE60319739D1 (de) 2008-04-24
JP2011037893A (ja) 2011-02-24
MY135468A (en) 2008-04-30
CA2511142A1 (en) 2004-07-08
AU2003287919B2 (en) 2009-11-12
CN100349885C (zh) 2007-11-21
BR0317623A (pt) 2005-11-29
PL378275A1 (pl) 2006-03-20
PT1578738E (pt) 2008-04-11
UA80170C2 (en) 2007-08-27
DK1578738T3 (da) 2008-06-30
MEP5808A (xx) 2010-02-10
PE20040924A1 (es) 2004-12-11
ES2298595T3 (es) 2008-05-16
AR042652A1 (es) 2005-06-29
TW200501943A (en) 2005-01-16
JP4658613B2 (ja) 2011-03-23
IL169125A0 (en) 2009-02-11
NO20053595L (no) 2005-09-05

Similar Documents

Publication Publication Date Title
DE50302478D1 (de) Elektrode und ein verfahren zu deren herstellung
DE50212077D1 (de) Piezoelektrisches bauelement und verfahren zu dessen herstellung
DE60332953D1 (de) Gleichmässiges faservlies und verfahren zu dessen herstellung
DE50310782D1 (de) Piezoaktor und verfahren zu dessen herstellung
DE60305105D1 (de) Aluminiumbeschichtetes Bauteil und Verfahren zu dessen Herstellung
DE60208867D1 (de) Ventil und ein Verfahren zu dessen Herstellung
DE60209104D1 (de) Selbstdichtender reifen und verfahren zu dessen herstellung
DE60202175D1 (de) Formwerkzeug und Verfahren zu dessen Herstellung
DE602004008991D1 (de) Umlenkbeschlag und verfahren zu dessen herstellung
DE50214272D1 (de) Piezoelektrisches bauelement und verfahren zu dessen herstellung
DE60313818D1 (de) Dialysator und Verfahren zu dessen Herstellung
DE50307832D1 (de) Schichtsystem und verfahren zu dessen herstellung
ATE388947T1 (de) Escitalopramhydrobromid und ein verfahren zu dessen herstellung
DE60224880D1 (de) Mikrobolometer und verfahren zu dessen herstellung
DE50305655D1 (de) Piezoaktor und ein verfahren zu dessen herstellung
AT5704U3 (de) Stopfpickel und verfahren zu dessen herstellung
DE60316056D1 (de) Nanoröhrenthermometer und ein Verfahren zu dessen Herstellung
DE50207733D1 (de) Nickelhydroxid und verfahren zu dessen herstellung
DE60238570D1 (de) Piezoelektrischer Oszillator und Verfahren zu dessen Herstellung
DE60323689D1 (de) Schräg geschichtetes furniermaterial und verfahren zu dessen herstellung
DE50010354D1 (de) Verbundteil und verfahren zu dessen herstellung
DE602004031350D1 (de) Penamkristall und verfahren zu dessen herstellung
DE60317717D1 (de) Faserverstärkter verbundwerkstoff und verfahren zu dessen herstellung
ATA3752003A (de) Verbundwerkstoff und verfahren zu dessen herstellung
DE60038384D1 (de) Polyarylen und verfahren zu dessen herstellung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1578738

Country of ref document: EP

REN Ceased due to non-payment of the annual fee